Break-through Infection Following Mpox vaccinatIon

CompletedOBSERVATIONAL
Enrollment

3,125

Participants

Timeline

Start Date

September 12, 2022

Primary Completion Date

March 30, 2024

Study Completion Date

March 30, 2024

Conditions
Mpox
Interventions
DRUG

Mpox Vaccine

Vaccination with smallpox and mpox vaccine (Live Modified Vaccinia Virus Ankara)

Trial Locations (6)

13011

Hospital Regional Docente de Trujillo, Trujillo

15082

Hospital Nacional Arzobispo Loayza, Lima

8360154

Hospital Clínico San Borja Arriarán, Santiago

Unknown

Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES), Panama City

Hospital Regional III Honorio Delgado, Arequipa

08916

Germans Trias i Pujol Hospital, Badalona

All Listed Sponsors
collaborator

Department of Health, Generalitat de Catalunya

OTHER_GOV

collaborator

Hospital Vall d'Hebron

OTHER

collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Hospital Universitario 12 de Octubre

OTHER

collaborator

Public Health Service of Madrid

OTHER

collaborator

Madrid Salud

OTHER

collaborator

Harvard School of Public Health (HSPH)

OTHER

collaborator

London School of Hygiene and Tropical Medicine

OTHER

collaborator

Germans Trias i Pujol Hospital

OTHER

collaborator

BCN Checkpoint

INDUSTRY

collaborator

Centro de Saluld Sandoval

UNKNOWN

collaborator

Centro de Salud Montesa

UNKNOWN

collaborator

Hospital Nacional Arzobispo Loayza

OTHER

collaborator

Hospital Regional III Honorio Delgado

UNKNOWN

collaborator

Hospital Regional Docente de Trujillo

UNKNOWN

collaborator

Instituto Conmemorativo Gorgas de Estudios de la Salud

UNKNOWN

collaborator

Ministerio de Salud de Panamá

UNKNOWN

collaborator

Fundación Arriaran

UNKNOWN

lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER